OPDIVO 10 mg/mL
nivolumab · INJECTION · E.R. Squibb & Sons, L.L.C.
No Recall History
Plain English
OPDIVO is a injection containing nivolumab at 10 mg/mL, taken intravenous. Manufactured by E.R. Squibb & Sons, L.L.C..
Key Facts
- Brand Name
- OPDIVO
- Generic Name
- nivolumab
- NDC Code (Product)
0003-3772- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Strength
- 10 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125554
- Drug Class
- Programmed Death Receptor-1 Blocking Antibody [EPC]
- Marketing Start
- 12/22/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is OPDIVO used for?
OPDIVO contains nivolumab. It is a injection taken intravenous. Consult your doctor for specific uses.
Is OPDIVO a controlled substance?
OPDIVO is not classified as a controlled substance by the DEA.
What is the generic name for OPDIVO?
The generic name for OPDIVO is nivolumab. There are 3 other brand versions of nivolumab.
What is the NDC code for OPDIVO 10 mg/mL?
The NDC (National Drug Code) for OPDIVO 10 mg/mL is 0003-3772, listed by E.R. Squibb & Sons, L.L.C..